Vliegenthart, A. D. B., Berends, C., Potter, C. M. J., Kersaudy‐Kerhoas, M., & Dear, J. W. (2017). MicroRNA‐122 can be measured in capillary blood which facilitates point‐of‐care testing for drug‐induced liver injury. British journal of clinical pharmacology, 83(9), 2027-2033. https://doi.org/10.1111/bcp.13282
Chicago Style (17th ed.) CitationVliegenthart, A. D. Bastiaan, Cécile Berends, Carmelita M. J. Potter, Maiwenn Kersaudy‐Kerhoas, and James W. Dear. "MicroRNA‐122 Can Be Measured in Capillary Blood Which Facilitates Point‐of‐care Testing for Drug‐induced Liver Injury." British Journal of Clinical Pharmacology 83, no. 9 (2017): 2027-2033. https://doi.org/10.1111/bcp.13282.
MLA (9th ed.) CitationVliegenthart, A. D. Bastiaan, et al. "MicroRNA‐122 Can Be Measured in Capillary Blood Which Facilitates Point‐of‐care Testing for Drug‐induced Liver Injury." British Journal of Clinical Pharmacology, vol. 83, no. 9, 2017, pp. 2027-2033, https://doi.org/10.1111/bcp.13282.